CCEL צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים Cryo-Cell International

A seamless express delivery network for biomaterials ensures the operational stability of Cryo-Cell International (CCEL). Analyzing the volatility of the quarterly EPS on GURU.Markets, we find that the current value is 69.30. An expanding base of long-term contracts and new cellular products are driving growth, while its status as a global leader in cryobanking creates a predictable stream of passive income through annual client payments.

Net income per share for Cryo-Cell International (CCEL) reflects the actual profitability of the business, which is subject to the inflationary cost increases of imported cryogenic equipment and consumables. By analyzing the quarterly EPS trend profile, an investor assesses the cash flow after taxes and subsidies, allowing them to filter out random fiscal spikes and confirm the stability of the company's fundamental asset value.